PTC Therapeutics, Inc. (PTCT) vs Sotera Health Company (SHC)

A side-by-side comparison of PTC Therapeutics, Inc. and Sotera Health Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — PTCT vs SHC

growth of $100 · dividends reinvested · last 6y
PTCT +3.1% (+0.5%/yr)SHC -26.1% (-4.9%/yr)PTCT compounded faster over this window
50100150Start $100202120222023202420252026$103$74
PTCT SHC

PTCT vs SHC: by the numbers

  • •PTCT is the larger company ($5.31B vs $5.21B market cap).
  • •SHC is profitable (13.44% net margin) while PTCT runs a net loss (-3.80%).
  • •PTCT grew revenue faster over the past five years (16.41% vs 6.66% CAGR).

Metrics side by side

Valuation

MetricPTCTSHC
P/E ratioN/A31.89
Forward P/E50.0218.54
P/S ratio5.264.28
P/B ratioN/A7.82
EV / EBITDA28.8612.43
FCF yieldN/A2.16%

Profitability

MetricPTCTSHC
Gross margin95.85%54.72%
Operating margin49.49%36.24%
Net margin-3.80%13.44%
ROEN/A24.56%
ROIC4.59%8.80%

Growth (annualized)

MetricPTCTSHC
Revenue CAGR (5Y)16.41%6.66%
FCF CAGR (5Y)N/A17.34%
Total return CAGR (5Y)11.75%-6.39%

Frequently asked

Which has grown faster, PTCT or SHC?
Over the past five years, PTCT grew revenue faster — PTCT at a 16.41% CAGR versus SHC at 6.66%.
Is PTCT or SHC more profitable?
SHC runs the higher net margin — PTCT at -3.80% versus SHC at 13.44%.
How have PTCT and SHC total returns compared?
Over the past 5 years, PTCT delivered 11.75% and SHC delivered -6.39% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.